|
|
Gamma emitting, CCK-A antagonists for pancreatic imaging
OF THE INVENTION The present invention is directed toward radiolabelled compounds of Formula I: ##STR2## wherein: A is ##STR3## R.sup.1 is H, C.sub.1 -C.sub.6 linear or ...
|
|
|
Optical amplifying device
FIG. 2 illustrates one embodiment of an amplifying device 10 wherein the laser device 110 is surface emitting with a number of active regions forming a "total active ...
|
|
|
Pharmaceutical delivery system
The present invention provides a method and means for dispensing in a controlled, continuous manner therapeutically effective amounts of water-soluble drugs for a ...
|
|
|
Nitrogen-containing cyclic ligands
We claim: 1. A ligand having the formula: ##STR44## in which R.sub.1 represents a radical of the formula: ##STR45## R.sub.6 being selected from the group consisting of C....
|
|
|
Conditioning shampoo
OF THE PREFERRED EMBODIMENT The conditioning shampoo composition of the preferred embodiment includes the following ingredients in the ranges, preferred ranges and best ...
|
|
|
Methods of diagnostic image analysis using lipophilic contrast agents
OF THE INVENTION The present invention is directed to complexing acids and salts thereof which when combined with a paramagnetic, ferromagnetic or diamagnetic metal ion ...
|
|
|
Method for increasing sensitivity to chemically induced terminal differentiation
OF THE INVENTION The present invention provides a method of selectively inducing terminal differentiation of neoplastic cells and thereby inhibiting proliferation of ...
|
|
|
Method for enhancing the safety of metal-ligand chelates as magnetic resonance imaging agents by addition of calcium ions
What is claimed is: 1. In a method for enhancing safety in the in vivo use of methal-ligand chelate complexes as magnetic resonance imaging agents comprising ...
|
|
|
Hydrated biodegradable superparamagnetic metal oxides
OF THE INVENTION 1. Preparation of Coated Superparamagnetic Iron Oxide Particles The synthesis of superparamagnetic iron oxide particles for use as MRI contrast agents ...
|
|
|
Halide-free process for the synthesis of ETS-10
OF THE INVENTION The present invention is directed towards crystalline titanium molecular sieve zeolites which have a pore size of approximately 8 Angstrom units and ...
|